Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shihan Yu

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical and Translational Hepatology|February 7, 2025
Ferrochelatase Gene Variants Associated with Cholestasis in Adults: A Case ReportXiaona Lu, Kun Liu, Wenlan Zheng, et al.
Rheumatology (Oxford, England)|February 22, 2022
Competitive binding of transcription factors underlies flexibility of T peripheral helper cells and T follicular helper cells in SLEQinglian Jiang, Jiakai Wang, Hongkun Jiang, et al.
Chinese Medicine|March 25, 2026
Gut microbiota-metabolism-immunity axis: a novel perspective of traditional Chinese medicine in hepatocellular carcinoma treatmentXuemei Zhang, Liming Zheng, Jia Shi, et al.
Frontiers in Immunology|April 7, 2023
Identification of key genes and imbalance of immune cell infiltration in immunoglobulin A associated vasculitis nephritis by integrated bioinformatic analysisXianxian Jia, Hua Zhu, Qinglian Jiang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 13, 2026
Early eculizumab treatment improves renal outcomes in pediatric lupus nephritis with thrombotic microangiopathyShihan Yu, Jie Zhang, Jia He, et al.
Journal of Hepatocellular Carcinoma|September 10, 2025
Newly Established Anoikis-Associated Genes Predict the Prognosis of Hepatocellular CarcinomaYuyao Li, Er Li, Wenlan Zheng, et al.
Biomaterials|August 24, 2024
Napabucasin deactivates STAT3 and promotes mitoxantrone-mediated cGAS-STING activation for hepatocellular carcinoma chemo-immunotherapyLingzhi Wang, Shengnan Bi, Zhuo Li, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical and Translational Hepatology|February 7, 2025
Ferrochelatase Gene Variants Associated with Cholestasis in Adults: A Case ReportXiaona Lu, Kun Liu, Wenlan Zheng, et al.
Rheumatology (Oxford, England)|February 22, 2022
Competitive binding of transcription factors underlies flexibility of T peripheral helper cells and T follicular helper cells in SLEQinglian Jiang, Jiakai Wang, Hongkun Jiang, et al.
Chinese Medicine|March 25, 2026
Gut microbiota-metabolism-immunity axis: a novel perspective of traditional Chinese medicine in hepatocellular carcinoma treatmentXuemei Zhang, Liming Zheng, Jia Shi, et al.
Frontiers in Immunology|April 7, 2023
Identification of key genes and imbalance of immune cell infiltration in immunoglobulin A associated vasculitis nephritis by integrated bioinformatic analysisXianxian Jia, Hua Zhu, Qinglian Jiang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 13, 2026
Early eculizumab treatment improves renal outcomes in pediatric lupus nephritis with thrombotic microangiopathyShihan Yu, Jie Zhang, Jia He, et al.
Journal of Hepatocellular Carcinoma|September 10, 2025
Newly Established Anoikis-Associated Genes Predict the Prognosis of Hepatocellular CarcinomaYuyao Li, Er Li, Wenlan Zheng, et al.
Biomaterials|August 24, 2024
Napabucasin deactivates STAT3 and promotes mitoxantrone-mediated cGAS-STING activation for hepatocellular carcinoma chemo-immunotherapyLingzhi Wang, Shengnan Bi, Zhuo Li, et al.
Pageof 2